James M. Frates
Chief Financial Officer
Chief Financial Officer at Amylyx Pharmaceuticals, Inc., filing insider transactions on 2026-09-10.
Total Purchases
—
0 transactions
Total Sales
$350K
2 transactions
Companies Traded
1
2 total filings
Active Since
2026-09-10
Last: 2026-09-10
Other Reporting Insiders at Amylyx Pharmaceuticals, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-09-10 | AMLX | Sale | 1,042 | $33.23 | $35K | 233.6K | SEC ↗ |
| 2026-09-10 | AMLX | Sale | 9,768 | $32.27 | $315K | 234.7K | SEC ↗ |
Director & Co-Chief Executive Officer